Scientists have known for years that maintaining an active lifestyle and taking time to exercise helps prevent cancer. But whether exercise improves survival rates for people who already have cancer was unclear. Now, a first-of-its kind international clinical trial provides the strongest clinical evidence to date that regular physical activity can help keep cancer at bay and prolong life.
The Colon Health and Life-Long Exercise Change or CHALLENGE trial, led by the Canadian Cancer Trials Group, enrolled 889 colon cancer patients across 55 treatment centers. Patients were randomized to a health education control group or a 3-year exercise intervention.
After nearly eight years of follow-up, the results were striking: patients in the exercise group had an overall 37% reduction in mortality compared to those in the health education control group. The overall survival was 90.3% in the exercise group versus 83.2% in the group that received educational materials alone.
Dr. Melinda Irwin, PhD, MPH, associate dean of research and the Susan Dwight Bliss Professor of Epidemiology (Chronic Diseases) at the Yale School of Public Health and deputy director of the Yale Cancer Center, is a leading authority on exercise, nutrition, and cancer. She recently took a moment to discuss the CHALLENGE trial results and what they mean for patients diagnosed with cancer.